HOT : Venetian Gondola Boat , Macau Tower , Galaxy 3 In 1 Package SINGAPORE, March 13, 2017 /PRNewswire/ -- Top Asian pharmas ASLAN Pharmaceutical, CPL Biologicals, MSD, Johnson & Johnson Innovation and Takeda Development Center for Asia will lead BioPharma Asia Convention 2017 in the Day 2 opening keynote plenary (23 March 2017 at Suntec Convention Centre, Singapore). FIRESIDE CHAT: From ideas to international success: A real breakthrough story brought to you by an Asian biotech company Starting from nothing to million-dollar success, this biotech company currently employs near hundred to benefit the healthcare industry. Hear from true blue biotech company in Asia on their success story in building the reach of their companies from domestic to international market. Speaker: Carl Firth, CEO, ASLAN Pharmaceutical, Singapore Interviewer: Ed Lane, Senior Editor, CNBC, Singapore Keynote Panel: Asia pharma perspective in driving innovation With the highest amount of resources which can be invested into operation, big pharma companies are in the best position to lead the industry direction. When making a key decision, it is important to understand the impact in organisation and industry wide. How can big pharma avoid being "too-big-to-fail" and lead the industry to be more innovative? How do local pharma and smaller biotech companies be more innovative to compete with their more established peers? Panellists:
Moderator: Ed Lane, Senior Editor, CNBC, Singapore 130 other pharma leaders are confirmed to speak at the BioPharma Asia Convention 2017 across 5 conferences - view more details. About BioPharma Asia Convention 2017 About Terrapinn Note: Press registration for the conference is compulsory and advance scheduling for speaker/ sponsor interviews is recommended. Final issuance of press passes is subjected to Terrapinn's discretion. For your press pass, please contact the following: News Sources
|